| Name | Title | Contact Details |
|---|---|---|
Wes Elfman |
VP, Enterprise Analytics | Profile |
Maria Latushkin |
Chief Technology Officer | Profile |
William Dougherty |
Vice President of Information Technology and Security | Profile |
Exogenesis Corporation is a Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Found is a modern weight care platform pioneering integrated support through personalized coaching, online community, and if indicated, prescription medication. We believe that weight care is complex and goes beyond having the willpower to eat less and move more. We believe in the power of biology, genetics, sleep, stress, mental health and daily habits and we work with each factor to achieve long-lasting results. Our goals are to address the long-term risks associated with ineffective weight management, to reimagine the narrow and outdated cultural narrative around weight, and to empower our community with tools that will help them find self-acceptance and add years to their lives. We believe it`s not just what you`ve lost, it`s what you`ve Found.
Cephalon is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
IGIhealth is a Piscataway, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.